The National Medical Products Administration (NMPA) of China released data on medical device approvals in March 2023. A total of 290 products were approved by the NMPA for market release, of which, 227 were domestic and 63 were import products.
As a comparison, in March 2022, 181 medical device products were approved by the NMPA, or a 60.2% growth in 2023. To date, a total of 576 approvals have been made by NMPA this year, a slight slide from the 587 approvals (-1.9%) in the first quarter 2022.